The drug regulator has granted Serum Institute of India's Covishield and Bharat Biotech's Covaxin Covid-19 vaccines "conditional market authorisation".
Ratings and research firm Icra has estimated that India's economy will grow at 9% in FY22 and FY23 amid the uncertainty triggered by the Omicron variant of Covid-19.
EXAMIANS